QSS
ACIU icon

Quantitative Systematic Strategies’s AC Immune ACIU Stock Holding History

Quantitative Systematic Strategies’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,757
Closed -$102K – 379
2018
Q4 		$102K Buy
+10,757
New +$102K 0.02% 605

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Quantitative Systematic Strategies's ACIU Position: Q1 2019 in Review

Quantitative Systematic Strategies sold out of AC Immune (ACIU) in Q1 2019, closing a stake of 10,757 shares — an estimated $102K sold.

Quantitative Systematic Strategies first reported a position in ACIU in Q4 2018 and held it in 1 quarter. The position peaked at $102K in Q4 2018. 41 funds tracked by Wall St. Rank hold ACIU as of Q1 2019.

  • Quantitative Systematic Strategies reported no remaining AC Immune position as of Q1 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 10,757 AC Immune shares in Q1 2019, an estimated $102K.
  • Quantitative Systematic Strategies first reported a position in AC Immune in Q4 2018 and held it in 1 quarter.
  • Quantitative Systematic Strategies's AC Immune position peaked at $102K in Q4 2018.
  • 41 funds tracked by Wall St. Rank held AC Immune as of Q1 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2019, filed 15 Apr 2019.